PHARMACOKINETICS OF HUMAN IMMUNOGLOBULIN G, 10%, ADMINISTERED INTRAVENOUSLY (IGIV), SUBCUTANEOUSLY (IGSC) OR FACILITATED SUBCUTANEOUSLY WITH RECOMBINANT HUMAN HYALURONIDASE (IGHY) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES

被引：0

作者：

Wasserman, R. L. ^{[1
]}

Melamed, I. ^{[2
]}

Stein, M. ^{[3
]}

Rubinstein, A. ^{[4
,5
]}

Puck, J. ^{[6
]}

Gupta, S. ^{[7
]}

Engl, W. ^{[8
]}

Leibl, H. ^{[8
]}

McCoy, B. ^{[8
]}

Gelmont, D. ^{[9
]}

Schiff, R. I. ^{[9
]}

机构：

[1] DallasAllergyImmunology, Dallas, TX USA

[2] IMMUNOe, Centennial, CO USA

[3] Allergy Associates Palm Beaches, N Palm Beach, FL USA

[4] Albert Einstein Coll Med, Bronx, NY 10467 USA

[5] Montefiore Hosp, Bronx, NY USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Univ Calif Irvine, Irvine, CA USA

[8] Baxter BioSci, Vienna, Austria

[9] Baxter BioSci, Westlake Village, CA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：136 / 136

页数：1

共 50 条

[41] Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Infusion Of Human Immune Globulin G (IgG), 10%, and Recombinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase 3 Extension Study In Patients With Primary Immunodeficiencies (PIs)
Melamed, Isaac Reuven
Wasserman, Richard L.
Stein, Mark
Rubinstein, Arye
Puck, Jennifer M.
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
Yel, Leman
Schiff, Richard I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB180 - AB180
[42] Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders
Sanford, Mark
BIODRUGS, 2014, 28 (04) : 411 - 420
[43] Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders
Mark Sanford
BioDrugs, 2014, 28 : 411 - 420
[44] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Subset of Study Patients With Primary Immunodeficiency Disease (PIDD)
Wasserman, R. L.
Melamed, I.
Stein, M.
Puck, J.
Gupta, S.
Engl, W.
Leibl, H.
Gelmont, D.
Schiff, R. I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB15 - AB15
[45] Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies
Stein, Mark R.
Wasserman, Richard L.
Melamed, Isaac
Gupta, Sudhir
Kobrynski, Lisa J.
Rubinstein, Arye
Rabbat, Christopher J.
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
[46] LONG TERM SAFETY, EFFICACY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE [RHUPH20]-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNOGLOBULIN G (IGG) (HYQVIA; IGHY) IN PEDIATRIC PATIENTS AGED <16 YEARS WITH PRIMARY IMMUNODEFICIENCIES (PID)
Wasserman, Richard L.
Melamed, Isaac
Stein, Mark
Kobrynski, Lisa
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 314 - 314
[47] Pharmacokinetic properties of Gammagard Liquid 10% (KIOVIG) administered intravenously and subcutaneously to patients with primary immunodeficiency diseases (PID)
Schiff, R., I
Leibl, H.
Engl, W.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 132 - 132
[48] REAL-WORLD USE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNOGLOBULIN G (IG) (IGHY; HYQVIA) IN PATIENTS (PTS) WITH PRIMARY IMMUNODEFICIENCY DISORDERS (PIDD)
Rosenbach, Kevin P.
Hughes, Stephanie M.
Rozen, Leon
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 271 - 272
[49] Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients
van Paassen, Pieter
Pittrow, David
Scheidegger, Clemens
Klotsche, Jens
Ellerbroek, Pauline M.
IMMUNOTHERAPY, 2020, 12 (02) : 131 - 139
[50] Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
Wasserman, Richard L.
IMMUNOTHERAPY, 2017, 9 (12) : 1035 - 1050

← 1 2 3 4 5 →